Atrás
Rango del Día
$23.50
$25.08
Rango de 52 Semanas
$4.66
$32.63
Volumen
131,559
Promedio 50D / 200D
$26.59
/
$19.96
Cierre Anterior
$23.44
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -22.2 | 0.2 |
| P/B | 2.9 | 3.0 |
| ROE % | -12.2 | 3.6 |
| Net Margin % | -106.4 | 3.8 |
| Rev Growth 5Y % | — | 9.9 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
Hold
$39.00
+61.1%
Low: $28.00
High: $60.00
EPS Futuro
-$1.64
Ingresos Est.
68.30M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
-$3.61
-$5.23 – -$2.04
|
84.30M | 2 |
| FY2029 |
-$3.52
-$5.09 – -$1.99
|
50.08M | 2 |
| FY2028 |
-$2.73
-$3.63 – -$1.76
|
63.70M | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-09 | -$0.25 | -$0.24 | +5.6% |
| 2025-11-10 | $0.19 | -$0.09 | -147.4% |
| 2025-08-11 | -$0.05 | -$0.56 | -1020.0% |
| 2025-05-15 | -$0.38 | -$0.49 | -28.9% |
| 2025-03-27 | -$0.69 | -$0.64 | +7.2% |
| 2024-11-21 | -$0.83 | -$8.40 | -912.0% |
| 2023-12-31 | N/A | $2.05 | — |
| 2023-09-30 | N/A | -$0.56 | — |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Puntos Clave
Debt/Equity of 0.06 — conservative balance sheet
Generating 109.67M in free cash flow
PEG of 0.30 suggests growth is underpriced
Capital efficient — spends only 1.13% of revenue on capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)4174.51%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-12.19%
ROIC-14.94%
Net Margin-106.37%
Op. Margin-175.83%
Seguridad
Debt / Equity
0.06
Current Ratio4.73
Interest Coverage0.00
Valoración
P/E Ratio
-22.24
Forward P/EN/A
P/B Ratio2.85
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4174.51% | Revenue Growth (3Y) | 1644.45% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 45.95M | Net Income (TTM) | -48.88M |
| ROE | -12.19% | ROA | -8.20% |
| Gross Margin | 100.00% | Operating Margin | -175.83% |
| Net Margin | -106.37% | Free Cash Flow (TTM) | 109.67M |
| ROIC | -14.94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.06 | Current Ratio | 4.73 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -22.24 | Forward P/E | N/A |
| P/B Ratio | 2.85 | P/S Ratio | 23.66 |
| PEG Ratio | 0.30 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 15.92 | Fwd Earnings Yield | N/A |
| FCF Yield | 10.09% | ||
| Market Cap | 1.09B | Enterprise Value | 990.09M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 45.95M | 1.08M | 151,000.0 | 0.0 |
| Net Income | -48.88M | -71.80M | 4.18M | -27.68M |
| EPS (Diluted) | -1.10 | -7.26 | 0.03 | -1.42 |
| Gross Profit | 45.95M | 1.08M | 151,000.0 | 0.0 |
| Operating Income | -80.80M | -80.82M | 2.08M | -27.97M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 596.19M | 456.55M | 130.87M | 36.12M |
| Total Liabilities | 214.26M | 36.51M | 169.24M | 80.32M |
| Shareholders' Equity | 381.93M | 420.05M | -38.37M | -44.20M |
| Total Debt | 23.63M | 25.48M | 12.57M | 710,000.0 |
| Cash & Equivalents | 120.72M | 238.20M | 88.48M | 30.61M |
| Current Assets | 410.96M | 356.82M | 112.68M | 31.89M |
| Current Liabilities | 86.93M | 12.85M | 6.91M | 5.54M |